We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
-15.62%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+557.96%
AUM
$163B
AUM Growth
+$35.8B
Cap. Flow
+$63.1B
Cap. Flow %
38.57%
Top 10 Hldgs %
39.01%
Holding
5,544
New
560
Increased
1,332
Reduced
2,502
Closed
413

Sector Composition

Rank Sector Weight
1 Technology 12.9%
2 Financials 7.33%
3 Healthcare 6.04%
4 Consumer Discretionary 5.46%
5 Communication Services 3.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IVOO icon
4051
Vanguard S&P Mid-Cap 400 ETF
IVOO
$3.83B
$31K ﹤0.01%
+400
New +$33.4K
KIDS icon
4052
OrthoPediatrics
KIDS
$595M
$31K ﹤0.01%
723
-1,587
-69% -$72.6K
MAX icon
4053
MediaAlpha
MAX
$821M
$31K ﹤0.01%
3,091
-2,323
-43% -$28.3K
QTRX icon
4054
Quanterix
QTRX
$190M
$31K ﹤0.01%
1,862
-3,385
-65% -$69.6K
REPL icon
4055
Replimune Group
REPL
$1.01B
$31K ﹤0.01%
1,826
-3,425
-65% -$56.3K
URGN icon
4056
UroGen Pharma
URGN
$2.29B
$31K ﹤0.01%
3,782
-3,169
-46% -$21.8K
GLLI
4057
DELISTED
Globalink Investment Inc. Common Stock
GLLI
$31K ﹤0.01%
+3,102
New +$30.8K
FREE
4058
DELISTED
Whole Earth Brands, Inc. Class A Common Stock
FREE
$31K ﹤0.01%
4,922
-4,028
-45% -$27.4K
BRQS
4059
DELISTED
Borqs Technologies, Inc. Ordinary Shares
BRQS
$31K ﹤0.01%
+1,563
New +$61.3K
ATC
4060
DELISTED
Atotech Limited
ATC
$31K ﹤0.01%
1,600
+1,446
+939% +$29.9K
ABSI icon
4061
Absci
ABSI
$1.51B
$30K ﹤0.01%
8,892
-8,533
-49% -$42.4K
CCCC icon
4062
C4 Therapeutics
CCCC
$412M
$30K ﹤0.01%
3,996
-23,647
-86% -$208K
IGSB icon
4063
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23B
$30K ﹤0.01%
+593
New +$30.2K
NSSC icon
4064
Napco Security Technologies
NSSC
$1.48B
$30K ﹤0.01%
1,475
-3,368
-70% -$63.4K
OCGN icon
4065
Ocugen
OCGN
$434M
$30K ﹤0.01%
+13,582
New +$32.5K
OUST icon
4066
Ouster
OUST
$2.92B
$30K ﹤0.01%
1,852
-1,471
-44% -$41.2K
XGN icon
4067
Exagen
XGN
$166M
$30K ﹤0.01%
5,216
-1,850
-26% -$10.8K
LILM
4068
DELISTED
Lilium N.V. Class A Ordinary Shares
LILM
$30K ﹤0.01%
12,855
-1,500
-10% -$4.71K
SHCR
4069
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
$30K ﹤0.01%
18,822
+17,630
+1,479% +$43.3K
CURO
4070
DELISTED
CURO Group Holdings Corp.
CURO
$30K ﹤0.01%
5,442
-2,401
-31% -$22K
GOEV
4071
DELISTED
Canoo Inc. Class A Common Stock
GOEV
$30K ﹤0.01%
34
-27
-44% -$47.5K
AMTI
4072
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
$30K ﹤0.01%
10,154
-4,115
-29% -$17.3K
CLOU icon
4073
Global X Cloud Computing ETF
CLOU
$263M
$29K ﹤0.01%
1,751
+1,716
+4,903% +$31.9K
CSTE icon
4074
Caesarstone
CSTE
$79.5M
$29K ﹤0.01%
3,269
-2,536
-44% -$24.3K
DX
4075
Dynex Capital
DX
$3.21B
$29K ﹤0.01%
1,825
-4,206
-70% -$66.8K

Similar funds

Barclays's Q2 2022 Portfolio in Review

As of Q2 2022, Barclays held 5,544 positions worth $163B, up 28% from $128B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Barclays deployed $63.1B of net new capital in Q2 2022, opening 560 new positions and adding to 1,332 existing holdings. Its largest new stake was Fisker Inc.: 3,607,227 shares worth $30.9M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.38B trimmed.

  • Barclays's largest Q2 2022 buy was Fisker Inc.: 3,607,227 shares worth $30.9M.
  • Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q2 2022, an estimated $1.04B increase.
  • Barclays's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.38B.
  • Barclays fully exited Cerner Corp in Q2 2022, selling an estimated $432M.
  • Barclays's ten largest holdings make up 39% of its $163B portfolio in Q2 2022.
  • Barclays opened 560 new positions and closed 413 in Q2 2022.
  • Barclays's portfolio value rose 28% quarter-over-quarter to $163B.

Based on Barclays's 13F filing for Q2 2022, filed 12 Aug 2022.